Commission Actions

Show: 20 | 50 | 100
Displaying 20 results
Displaying 1 - 20 of 31467

Pages

November 19, 2019

Press Release: FTC Submits Comment in Favor of Amendments to North Carolina’s Administrative Code that would Promote Expanded Access to Preventive Dental Services
Press Release: FTC Issues Agency Financial Report for Fiscal Year 2019
Press Release: FTC Approves Final Order Imposing Conditions on US Foods Holding Corp.’s Acquisition of Services Group of America, Inc.
Press Release: California Company Settles FTC Allegations that it Falsely Claimed Participation in EU-U.S. Privacy Shield
Case: Nerium International, LLC
Matter Number: 162 3099
Case: US Foods and SGA, In the Matter of
Matter Number: 181 0215
Case: Medable, Inc., In the Matter of
Matter Number: 182 3192
Advocacy Filing: FTC Staff Comment to the North Caroline State Board of Dental Examiners Regarding Proposed Rule Changes to 21 N.C. Admin. Code 16W
Matter Number: V200003

November 18, 2019

Public Event: Cmr. Wilson keynote address to Family Online Safety Institute. U.S. Institute of Peace
Public Event: Cmr. Slaughter panelist at IAPP Europe Data Protection Congress 2019
Public Event: Cmr. Slaughter opening remarks at “Competition Policy and Economics: What's Gender Got to Do With It?” conference
Public Event: Cmr. Wilson panelist at American Bar Association 2019 Fall Forum Tech Summit
Public Event: Cmr. Phillips panelist at American Bar Association 2019 Fall Forum Tech Summit
Public Event: Cmr. Slaughter panelist at American Bar Association 2019 Fall Forum Tech Summit
Public Event: Chmn. Simons keynote at American Bar Association 2019 Antitrust Fall Forum Tech Summit

November 15, 2019

Public Statement: Statement of Commissioner Noah Joshua Phillips In the Matter of Bristol-Myers Squibb Company and Celgene Corporation
Matter Number: 191 0061
Public Statement: Dissenting Statement of Commissioner Rohit Chopra In the Matter of Bristol-Myers Squibb Company and Celgene Corporation
Matter Number: 191 0061
Public Statement: Dissenting Statement of Commissioner Rebecca Kelly Slaughter In the Matter of Bristol-Myers Squibb Company and Celgene Corporation
Matter Number: 191 0061
Public Statement: Statement of Commissioner Christine S. Wilson In the Matter of Bristol-Myers Squibb Company and Celgene Corporation
Matter Number: 191 0061
Press Release: FTC Requires Bristol-Myers Squibb Company and Celgene Corporation to Divest Psoriasis Drug Otezla as a Condition of Acquisition

Pages